Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi) announced today that it has received approval for a partial amendment to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback